These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31158374)

  • 1. Toward More Accurate Nomenclature for Fatty Liver Diseases.
    Eslam M; Sanyal AJ; George J
    Gastroenterology; 2019 Sep; 157(3):590-593. PubMed ID: 31158374
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Hansen CD; Lindvig KP; Grønbæk H; Gluud LL; Thiele M; Krag A
    Ugeskr Laeger; 2024 May; 186(19):. PubMed ID: 38808766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.
    Toshikuni N; Tsutsumi M; Arisawa T
    World J Gastroenterol; 2014 Jul; 20(26):8393-406. PubMed ID: 25024597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies.
    Åberg F; Färkkilä M; Männistö V
    Alcohol Clin Exp Res; 2020 Feb; 44(2):384-403. PubMed ID: 31854001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol and Liver Transplantation.
    Testino G; Leone S
    Alcohol Alcohol; 2017 Jan; 52(1):126. PubMed ID: 27600939
    [No Abstract]   [Full Text] [Related]  

  • 6. [The incidence of alcoholic liver disease in Japan].
    Yamauchi M; Ohata M
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():220-5. PubMed ID: 11838118
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic challenges in alcohol use disorder and alcoholic liver disease.
    Vonghia L; Michielsen P; Dom G; Francque S
    World J Gastroenterol; 2014 Jul; 20(25):8024-32. PubMed ID: 25009373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of new fatty liver disease nomenclature on primary care- cerebration of gastroenterologists in a regional tertiary care hospital.
    Chen X; Liu D; Li R
    Ann Hepatol; 2024; 29(3):101486. PubMed ID: 38403069
    [No Abstract]   [Full Text] [Related]  

  • 9. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
    Eslam M; Sanyal AJ; George J;
    Gastroenterology; 2020 May; 158(7):1999-2014.e1. PubMed ID: 32044314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.
    Polyzos SA; Kang ES; Tsochatzis EA; Kechagias S; Ekstedt M; Xanthakos S; Lonardo A; Mantovani A; Tilg H; Côté I; Grefhorst A; Greene MW; Araujo-Vilar D; Alisi A; Casanueva F; Mantzoros CS
    Metabolism; 2020 Dec; 113():154413. PubMed ID: 33164861
    [No Abstract]   [Full Text] [Related]  

  • 11. The New Nomenclature for Fatty Liver Disease.
    Francque SM; Procopet B
    J Gastrointestin Liver Dis; 2024 Jun; 33(2):149-151. PubMed ID: 38944849
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease?
    Softic S; Kahn CR
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):143. PubMed ID: 30507644
    [No Abstract]   [Full Text] [Related]  

  • 13. How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?
    Sookoian S; Pirola CJ
    Gastroenterology; 2016 Jun; 150(8):1698-1703.e2. PubMed ID: 26775630
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correspondence: "A multisociety Delphi consensus statement on new fatty liver disease nomenclature".
    Wan KS; Chan WK; Yusoff MFM; Mustapha F; Rifin HM; Ratnam KKY; Ahmad NA
    Ann Hepatol; 2024; 29(4):101485. PubMed ID: 38403072
    [No Abstract]   [Full Text] [Related]  

  • 16. Adolescent Alcoholic Liver Disease.
    Taylor SA; Miloh T
    Clin Liver Dis; 2019 Feb; 23(1):51-54. PubMed ID: 30454832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the global cirrhosis epidemic: one size will not fit all.
    Wang PL; Flemming JA
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):230-231. PubMed ID: 31981522
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of ANI in differentiating between alcoholic liver disease and nonalcoholic fatty liver disease].
    Wang J; Li P; Jiang Z; Yang Q; Liu Y; Shi R; Mi Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):136-9. PubMed ID: 26983484
    [No Abstract]   [Full Text] [Related]  

  • 19. Is it time to change NAFLD and NASH nomenclature?
    Bellentani S; Tiribelli C
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):547-548. PubMed ID: 28691681
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic liver disease in alcohol-related chronic pancreatitis patients: Does lightning strike twice?
    Soni A; Singh B; Nijhawan S; Mathur A; Gupta G
    Indian J Gastroenterol; 2015 Jul; 34(4):345-6. PubMed ID: 26024741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.